The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - InnoPharmax
Stock and Other Ownership Interests - InnoPharma
 
Consulting or Advisory Role - HERON
Speakers' Bureau - Onyx
An open-label, exploratory, limited dose escalation study to evaluate the pharmacokinetics, safety and tolerability of gemcitabine hydrochloride oral formulation in subjects with malignant tumors.
 
Nashat Y. Gabrail
Consulting or Advisory Role - Boehringer Ingelheim; Onyx; Sanofi
Speakers' Bureau - Onyx
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); HERON (Inst); Incyte (Inst); Sanofi (Inst); Tesaro (Inst)
 
Sharad A. Ghamande
Research Funding - Astex Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Endocyte (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); Takeda (Inst)
 
Michael H. Silverman3
Stock and Other Ownership Interests - Can-Fite BioPharma; Dipexium
Consulting or Advisory Role - Angstrom Pharmaceuticals; Berg Pharma; Can-Fite BioPharma; Cleave Biosciences; Gem Pharmaceuticals; Immune System Key; InnoPharma; Onconova Therapeutics; Phosplatin Therapeutics; Sanofi; Taiwan Liposome; Verastem
 
Carrie L. Smith
No Relationships to Disclose
 
Hsiang-Ling Ho
Employment - InnoPharmax
Stock and Other Ownership Interests - InnoPharmax
 
Chia-Tsung Huang
Employment - InnoPharmax
Stock and Other Ownership Interests - InnoPharmax
 
Shu-Ping Hsueh
Employment - InnoPharmax
Stock and Other Ownership Interests - InnoPharmax
 
Chia-Li Lin
No Relationships to Disclose